These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 10389953)

  • 1. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
    Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
    Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect.
    Wright SW; Norris RL; Mitchell TR
    Ann Emerg Med; 1992 Aug; 21(8):925-8. PubMed ID: 1497158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.
    Weiner DL; Hibberd PL; Betit P; Cooper AB; Botelho CA; Brugnara C
    JAMA; 2003 Mar; 289(9):1136-42. PubMed ID: 12622584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous ketorolac and subarachnoid opioid analgesia in the management of acute postoperative pain.
    Gwirtz KH; Kim HC; Nagy DJ; Young JV; Byers RS; Kovach DA; Li W
    Reg Anesth; 1995; 20(5):395-401. PubMed ID: 8519716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?
    Dhebaria T; Sivitz A; Tejani C
    Acad Emerg Med; 2021 Jun; 28(6):639-646. PubMed ID: 33025690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness.
    Beiter JL; Simon HK; Chambliss CR; Adamkiewicz T; Sullivan K
    Arch Pediatr Adolesc Med; 2001 Apr; 155(4):496-500. PubMed ID: 11296078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis.
    Perlin E; Finke H; Castro O; Rana S; Pittman J; Burt R; Ruff C; McHugh D
    Am J Hematol; 1994 May; 46(1):43-7. PubMed ID: 7514356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ketorolac in sickle-cell disease and vaso-occlusive crisis.
    Goodman E
    Lancet; 1991 Sep; 338(8767):641-2. PubMed ID: 1679183
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
    Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
    Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
    Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ketorolac in children with forearm fractures.
    Pierce MC; Fuchs S
    Acad Emerg Med; 1997 Jan; 4(1):22-6. PubMed ID: 9110007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches.
    Seim MB; March JA; Dunn KA
    Acad Emerg Med; 1998 Jun; 5(6):573-6. PubMed ID: 9660282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department.
    Sanders DY; Severance HW; Pollack CV
    South Med J; 1992 Aug; 85(8):808-11. PubMed ID: 1302470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ketorolac and morphine as adjuvants during pediatric surgery.
    Watcha MF; Jones MB; Lagueruela RG; Schweiger C; White PF
    Anesthesiology; 1992 Mar; 76(3):368-72. PubMed ID: 1539847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain.
    Innes GD; Croskerry P; Worthington J; Beveridge R; Jones D
    J Emerg Med; 1998; 16(4):549-56. PubMed ID: 9696169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative pain after lumbar disc surgery: a comparison between parenteral ketorolac and narcotics.
    Le Roux PD; Samudrala S
    Acta Neurochir (Wien); 1999; 141(3):261-7. PubMed ID: 10214482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.
    Gillis JC; Brogden RN
    Drugs; 1997 Jan; 53(1):139-88. PubMed ID: 9010653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department.
    Gonzalez ER; Bahal N; Hansen LA; Ware D; Bull DS; Ornato JP; Lehman ME
    Arch Intern Med; 1991 Jul; 151(7):1373-8. PubMed ID: 2064488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.